Kinetic segregation gated Chimeric Antigen Receptors
Chimeric Antigen Receptor (CAR) T cell therapy has had unprecedented success in the treatment of haematological malignancies, this is especially true in clinical trials targeted against CD19 for the treatment of paediatric Acute Lymphoblastic Leukaemia (ALL) and Chronic Lymphocytic Leukaemia (CLL)....
Main Author: | Kong, Khai Jien |
---|---|
Published: |
University College London (University of London)
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.746389 |
Similar Items
-
Affinity gradient of chimeric antigen receptor T-cells against low-antigen density target
by: Kokalaki, E. K.
Published: (2017) -
Development of c-Met targeted chimeric antigen receptor T-cell immunotherapy for malignant pleural mesothelioma
by: Thayaparan, Thivyan
Published: (2016) -
Investigating the activity of L1 chimeric transcripts in human cancer
by: Xu, Hang
Published: (2016) -
Differential expression of C/T antigens and 5-HT receptors in normotensive and pre-eclamptic placentae, and their role in trophoblast invasion
by: Tamang, A. P.
Published: (2015) -
Retroviral targeting to tumour antigens
by: Chowdhury, S.
Published: (2004)